JeffreyRobertLaducaMD

PubMed

• 28 citations
  The G2028R glycine substitution mutation in COL7A1 leads to marked inter-familiar clinical heterogeneity in dominant dystrophic epidermolysis bullosa.
  Hiroyuki Nakamura, Daisuke Sawamura, Maki Goto, Kazuko C. Sato-Matsumura, Jeffrey R. LaDuca, Julia Yu-Yun Lee, Takuji Masunaga, Hiroshi Shimizu> ;Journal of Dermatological Science. 2004 May 1
• 12 citations
  Nonsteroidal antiinflammatory drug-induced pseudoporphyria: a case series.
  Jeffrey R. LaDuca, Peter H. Bouman, Anthony A. Gaspari> ;Journal of Cutaneous Medicine and Surgery. 2002 Jul 1
• 64 citations
  Targeting tumor necrosis factor alpha. New drugs used to modulate inflammatory diseases.
  Jeffrey R. LaDuca, Anthony A. Gaspari> ;Dermatologic Clinics. 2001 Oct 1
• 2 citations
  Tumorigenesis of rat mammary epithelial cells by N-nitroso-N-methylurea in an in vitro system: characterization of the microtumors.
  Jeffrey R. Laduca, Dilip K. Sinha> ;In Vitro Cellular & Developmental Biology. Animal. 1996 Apr 1
• 3 citations
  In vitro carcinogenesis of mammary epithelial cells by N-nitroso-N-methylurea using a collagen gel matrix culture
  Jeffrey R. Laduca, Dilip K. Sinha> ;In Vitro Cellular & Developmental Biology. Animal. 1993 Oct 1
• CADASIL: the dermatologic diagnosis of a neurologic disease. Cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy.
  Rumbaugh, J. A., LaDuca, J. R., Shan, Y., Miller, C. A.> ;J Am Acad Dermatol. 2000 Dec
• Evaluation of Schistosoma mansoni retinoid X receptor (SmRXR1 and SmRXR2) activity and tissue distribution.
  Fantappie, M. R., Freebern, W. J., Osman, A., LaDuca, J., Niles, E. G., LoVerde, P. T.> ;Mol Biochem Parasitol. 2001 Jun
• Join now to see all

Journal Articles

• The G2028R Glycine Substitution Mutation in COL7A1 Leads to Marked Inter-Family Clinical Heterogeneity in Dominant Dystrophic Epidermolysis Bullosa.  
  H. Nakamura, D. Sawamura, M. Goto, K. Sato-Matsumura, J. LaDuca, J. Lee, T Masungaga, H Shimizu, J Dermatological Sciences
• Medical Uses of Thalidomide: Past, Present and Future.  
  K.Q. Lu, J.R. LaDuca, A.A, Gaspari, Progress in Dermatology
• CD4-penic Patient without HIV or HTLV Develops and HHV8 Associated Kaposi’s Sarcoma and a T-cell Lymphoma.  
  J.R. LaDuca, J.L. Love, L.Z. Abbott, S. Dube, W. Macon, S. Atwood, T. Cummins, B.J. Poiesz, Br HIV Arch
• Thalidomide Therapy for Managing Chronic Cutaneous Lupus Erythematosus: Historical and Practical Considerations.  
  J.R. LaDuca, D.N. Herrmann, and A.A. Gaspari, Dermatologic Therapy
• Thalidomide: An Old Drug for the New Mellenium.  
  J.R. LaDuca, A.A, Gaspari, P&T (Pharmacy and Therapeutics)
• Detection of Human Herpesvirus 8 DNA Sequences in Tissues and Bodily Fluids.  
  J.R. LaDuca, J.L. Love, L.Z. Abbott, S. Dube, A.E. Freidman-Kien, B.J. Poiesz, J Infectious Diseases
• Oncogenes and Tumor Suppressor Genes in Human Breast Cancer.  
  J.R. LaDuca, S.Dube, B.J. Poiesz, Arch STD/HIV
• Tumorogenesis of Rat Mammary Epithelial Cells by N-Nitroso-N-Methylurea in an In Vitro System: Characterization of The Microtumors in Vitro Cell and Mol Biology.  
  J.R. LaDuca, D.K. Sinha, Animal
• In Vitro Carcinogenesis of Mammary Epithelial Cells by N-Nitroso-N-Methylurea Using a Collagen Gel Culture. In Vitro Cell and Mol. Biology.  
  J.R. LaDuca, D.K. Sinha, Animal
• Join now to see all

Books/Book Chapters

• Diseases In General Medicine. 
  Chapter: The Aminoquinolines 
  Page 2157 - 2163J.R. LaDuca, A.A. GaspariEditors: Fitzpatrick.Edition 7,
• Diseases In General Medicine. 
  Chapter: The Aminoquinolines 
  Page 2392 - 2397J.R. LaDuca, A.A. GaspariEditors: Fitzpatrick.Edition 6,